Rational drug design, synthesis and biological evaluation of dihydrofolate reductase inhibitors as antituberculosis agents
dc.contributor.author | Tawari, N. R. | |
dc.contributor.author | Bag, S. | |
dc.contributor.author | Raju, A. | |
dc.contributor.author | Ray, M. K. | |
dc.contributor.author | Rajan, M. G. R. | |
dc.date.accessioned | 2016-06-15T09:50:21Z | |
dc.date.available | 2016-06-15T09:50:21Z | |
dc.date.issued | 2015 | |
dc.description.division | RMC | en |
dc.format.extent | 4465 bytes | |
dc.format.mimetype | text/html | |
dc.identifier.source | Future Medicinal Chemistry, 2015. Vol. 7 (8): pp. 979-988 | en |
dc.identifier.uri | http://hdl.handle.net/123456789/13134 | |
dc.language.iso | en | en |
dc.subject | Rational drug design | en |
dc.subject | synthesis and biological evaluation | en |
dc.subject | dihydrofolate | en |
dc.subject | antituberculosis agents | en |
dc.title | Rational drug design, synthesis and biological evaluation of dihydrofolate reductase inhibitors as antituberculosis agents | en |
dc.type | Article | en |